Tanshinone IIA preconditioning enhances the therapeutic efficacy of mesenchymal stem cells in Alzheimer’s disease
BackgroundMesenchymal stem cells (MSCs) have the potential to treat Alzheimer’s disease (AD), but their therapeutic efficacy is limited by apoptosis and other complications during in vitro culture.